SCHEMBL7817469

SCHEMBL7817469

CC(C)OC(=O)C(C)(C)Oc1cccc(C2=CCN(C(=O)c3ccncc3)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 8/20 0.44
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
SLC6A7 Q99884 1/20 0.38
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CCNT1 O60563 1/20 0.36
CDK9 P50750 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813905 0.93 ALDH1A1 (0.46) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7804444 0.92 NAMPT (0.44) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7810075 0.91 NAMPT (0.47) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7813624 0.90 POLB (0.40) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7814015 0.90 NAMPT (0.44) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7811486 0.90 PPARG (0.49) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7809885 0.90 POLB (0.41) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7817528 0.90 NAMPT (0.49) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7804398 0.88 PPARG (0.49) NAMPTALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL7804294 0.88 HPGD (0.39) NAMPTALDH1A1HPGDSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed